Expert Consulting and Expert Witness Services

  home    |    expert directory    |    using intota    |    about us    |    blog    |    contact us    |    request an expert     expert login & enrollment  
  
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  727557

Expert in Intellectual Property, Licensing, Biopharma, Pharma, Medical Devices, Chemisty


Available for your Consulting and Expert Witness Needs

Colorado (CO)
USA
Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness Market Research

Summary of Expertise:

Listed with other top experts in: 

Expert has more than 20 years of expertise in intellectual property, transactional and regulatory counseling, acquisition, licensing, due diligence, dispute resolution, opinions, and appeals for the development and commercialization of health care, pharmaceutical, biotechnology, chemical, computer and electronics technologies. With more than 10 years of in house and 10 years of law firm experience, Expert has supported the intellectual property, transactional, regulatory, and related legal business needs of small, medium and global high technology companies in the United States, Europe and Asia.

In addition to managing more than 50 patent and regulatory product portfolios, Expert has drafted more than 500 patent applications, prosecuted more than 1000 US patent applications & managed worldwide patent prosecution for more than 500 patent families. He has also worked on trademark and copyright matters, including drafting, prosecution and clearances. Expert has managed up to 10 attorneys, patent agents, paralegals, and administrative staff.

Expert has also conducted more than 100 major product and company transactional and IP due diligences, negotiations and agreements, as well as more than 1000 agreement negotiations and drafting, including academic, non-profit, government, feasibility, research, service, investigator initiated clinical studies, clinical studies and master agreements, manufacturing, product and technology licensing, know how and patent licenses, acquisitions, and product & technology out-licensing.

In the US, Expert has worked on more than more than 50 appeals to the Board of Patent Appeals and Interferences and the Federal Circuit, 15 patent interferences, including District Court and Federal Circuit appeals (such as the Fiers v. Sugano biotechnology Federal Circuit appeal),15 reexaminations, and 10 reissues.

In the European Union, Expert has managed prosecution of more than 150 EPO patent applications in more than 20 EU countries and has managed more than 15 patent oppositions & appeals. In Japan, he has managed the prosecution of more than 100 patent applications & 10 appeals.

Expert has presented, managed & developed more than 50 in house & public presentations relating to various aspects of US & international patent, regulatory, dispute resolution, & related IP & transactional issues.

Expert has worked on international pharmaceutical & biotechnology dispute resolution & patent litigation, including patent arbitrations & litigation in the US, EU, & Japan. Expert has also worked for more than 10 years as in house patent & business development counsel at Johnson & Johnson & Eli Lilly.

Expert began his legal career with several large law firms representing various pharmaceutical, medical device, biotech, chemical, plant & other life sciences companies.

Before attending law school, Expert worked as a molecular biologist at the NIH studying DNA repair & cytochrome p450 expression, characterization, enzymology & monoclonal antibody inhibition in recombinant vaccinia, retrovirus & baculovirus expression systems, including analysis using spectroscopy, protein expression and purification, enzyme kinetics, and nucleic acid analysis.

 • 

biotechnology patent law

 • 

defensive patenting

 • 

international licensing

 • 

patent application

 • 

patent infringement

 • 

patent prosecution

 • 

patent specification

 • 

bioinformatics

 • 

bioprocessing

 • 

biotechnology

 • 

business development

 • 

drug

 • 

drug delivery

 • 

drug development

 • 

drug discovery

 • 

drug screening

 • 

drug validation

 • 

Food and Drug Administration regulation

 • 

intellectual property

 • 

intellectual property licensing

 • 

international technology transfer

 • 

pharmaceutical drug

 • 

pharmaceutical manufacturing

 • 

pharmaceutical product development

 • 

pharmaceutical product formulation

 • 

pharmaceutical research

 • 

pharmaceutical research and development

 • 

pharmacogenomics

 • 

proteomics

 • 

technology licensing


Show Secondary and Basic Areas of Expertise
Localities:
Expert may consult nationally and internationally, and is also local to the following cities: Denver, Colorado;  Colorado Springs, Colorado;  Aurora, Colorado;  Fort Collins, Colorado;  Arvada, Colorado;  Pueblo, Colorado;  Westminster, Colorado;  Boulder, Colorado;  Greeley, Colorado;  and Longmont, Colorado.

Education:
Year   Degree   Subject   Institution   Honors
1993   J.D.   Intellectual Property and Licensing Law   George Mason School of Law   Honor Roll
1983   M.S.   Zoology (Biochemistry, Molecular Genetics and Endocrinology)   University of Maryland   Honor Roll
1980   B.S.   Zoology   Duke University   Honor Roll

Work History:
Years   Employer   Department   Title   Responsibilities

2011 to

 

(Undisclosed)

 

Intellectual Property

 

Special Counsel

 

Business development, licensing, acquisition, transactional, due diligence, Intellectual property, & regulatory counseling, dispute resolution, opinions, & appeals for the development, manufacturing & commercialization of high and clean technology, health care, medical devices, plant, pharmaceutical, chemical, and biotechnology, diagnostic devices, mechanical, and computer related products & technologies. Management of attorneys, patent agents, paralegals and administrative staff.

2008 to 2010

 

Hogan Lovells LLP

 

IPMT

 

Partner

 

Business development, licensing, acquisition, transactional, due diligence, Intellectual property, & regulatory counseling, dispute resolution, opinions, & appeals for the development, manufacturing & commercialization of high and clean technology, health care, medical devices, plant, pharmaceutical, chemical, and biotechnology, diagnostic devices, mechanical, and computer related products & technologies. Management of attorneys, patent agents, paralegals and administrative staff.

2000 to 2008

 

Johnson & Johnson/Centocor

 

Patent Law Department

 

Assistant Patent Counsel

 

Sole responsibility for REMICADE™ , J&J's Largest Product (>$4Billion annual sales). Transactional/ acquisition/licensing/ counseling/management of global biotech, plant, and pharmaceutical IP issues, analysis & strategic planning for products and technologies in all stages of development, relating to discovery, technology development, product development, formulation, administration, manufacturing, clinical development & marketing; licensing in & out (due diligence, negotiations & agreement drafting) of patents, 10-12 products, technologies, M&A, regulatory issues, litigation counseling; opinions; managing in house & outside patent counsel & litigation counsel, attorneys, patent agents, paralegals and administrative staff; members of management committee relating to patent, regulatory, manufacturing, discovery, clinical, licensing & marketing; managing invention disclosures, patent applications, patent portfolios, foreign filing portfolios, & strategic licensing; personal drafting of 15-25 patent applications/year, managing worldwide patent portfolios for products on market & in development, including US, EU & Japanese patent prosecution, oppositions, appeals, litigation preparation, & arbitration. Health care, plant, pharmaceutical, chemical, and biotechnology, medical and diagnostic device, chemical, mechanical, and computer related products & technologies. Subject matter including medical device related work included diagnostic assays and kits, intra-articular, IV, intramuscular, subcutaneous, transdermal, inhalation, intranasal, and oral administration devices, formulations, combinations, and dosing for chemical and biotech drugs, antibodies, proteins, vaccines, chemicals, devices, business methods, software. Management of attorneys, patent agents, paralegals and administrative staff.

1998 to 1999

 

Eli Lilly and Company

 

Patent Department

 

Senior Patent Counsel

 

Counseling/management/acquisition/transactions relating to global biotech, plant, chemical, and pharmaceutical IP issues, analysis & strategic planning for 5-10 products in all stages of development, securing freedom to operate from 3rd party patents relating to discovery, technology development, product development, formulation, administration, manufacturing, clinical development & marketing; representation of company on priority IP issues & projects as part of products teams, cross functional teams, & R&D, preclinical, manufacturing, clinical development, managing in house & outside patent counsel & litigation counsel, attorneys, patent agents, paralegals and administrative staff; members of management committee relating to patent, regulatory, manufacturing, discovery, clinical, licensing & marketing; managing of invention disclosures, patent applications, patent portfolios, foreign filing portfolios, & strategic licensing; drafing & personal drafting of 50-60 patent applications/year. Subject matter including medical device related work included diagnostic assays and kits, intra-articular, IV, intramuscular, subcutaneous, transdermal, inhalation, intranasal, and oral administration devices, formulations, combinations, and dosing for chemical and biotech drugs, antibodies, proteins, vaccines, chemicals, devices, business methods, software. Management of attorneys, patent agents, paralegals and administrative staff.

1994 to 1998

 

Sterne, Kessler, Goldstein and Fox, LLP

 


 

Senior Associate

 

Biotech, Chemical, Device & Software IP counseling, licensing, product clearances, infringement & invalidity opinions, patent drafting, prosecution & appeals & interferences, chemical, biotech & pharma companies, academic & non-profit institutions, including NIH/government licensing. Trademark matters, including drafting, prosecution and clearances. Personal drafting of 30-40 patent applications/year. Subject matter including medical device related work included diagnostic assays and kits, intra-articular, IV, intramuscular, subcutaneous, transdermal, inhalation, intranasal, and oral administration devices, formulations, combinations, and dosing for chemical and biotech drugs, antibodies, proteins, vaccines, chemicals, devices, business methods, software. Management of attorneys, patent agents, paralegals and administrative staff

1992 to 1994

 

Browdy & Neimark

 


 

Patent Agent

 

Chemical, biotech & mechanical patent licensing, product clearances, infringement & invalidity opinions, patent drafting, prosecution & appeals & interferences, for chemical, biotech & pharma companies, & for academic & non-profit institutions. Trademark matters, including drafting, prosecution and clearances. Personal drafting of 40-50 patent applications/year. Subject matter including medical device related work included diagnostic assays and kits, intra-articular, IV, intramuscular, subcutaneous, transdermal, inhalation, intranasal, and oral administration devices, formulations, combinations, and dosing for chemical and biotech drugs, antibodies, proteins, vaccines, chemicals, devices, business methods, software. Management of patent agents, paralegals and administrative staff.

1990 to 1992

 

Sughrue, Mion, Zinn, Macpeak & Seas, LLP

 

Intellectual Property

 

Patent Agent

 

Chemical, biotech & mechanical patent infringement & invalidity opinions, patent drafting, prosecution & appeals & interferences, for chemical, biotech & pharma companies, academic & non-profit institutions. Personal drafting of 40-50 patent applications/year. Trademark matters, including drafting, prosecution and clearances. Subject matter including medical device related work included diagnostic assays and kits, intra-articular, IV, intramuscular, subcutaneous, transdermal, inhalation, intranasal, and oral administration devices, formulations, combinations, and dosing for chemical and biotech drugs, antibodies, proteins, vaccines, chemicals, devices, business methods, software. Management of patent agents, paralegals and administrative staff.

1983 to 1988

 

National Institutes of Health

 

Molecular and Cellular Carcinogenesis

 

Molecular Biologist, GS-9

 

Chemical & biological analysis of : (a) DNA repair in xeroderma pigmentosum patients & cloning & expression of cytochrome p-450s in vaccinia, retrovirus & baculovirus expression systems, characterization, antibodies & enzyme assay development & kinetics, including protein, DNA and RNA analysis, enzyme and protein spectroscopy and mass spectroscopy, and gene expression analysis.


Career Accomplishments:
Associations/Societies

AIPLA, LES

Licenses/Certifications

USPTO Reg; PA Bar; Colorado Bar (Pending)


Publications:
Publications and Patents Summary

Expert has drafted more than 500 patent applications, prosecuted more than 1000 US patent applications & managed worldwide patent prosecution for more than 500 patent families. Exemplary Patents: Medical Devices/ Organic Chemistry/Pharmaceuticals/Fluorescence/Biotechnology.


Consulting Services:
Selected Consulting Examples:
  • Expert has provided transactional/ acquisition/licensing/ counseling/ management of global biotech, plant, and pharmaceutical IP issues, analysis & strategic planning for products and technologies in all stages of development, relating to discovery, technology development, product development, formulation, administration, manufacturing, clinical development & marketing; licensing in & out (due diligence, negotiations & agreement drafting) of patents, 10-12 products, technologies, M&A, regulatory issues, litigation counseling; opinions; managing in house & outside patent counsel & litigation counsel, attorneys, patent agents, paralegals and administrative staff; members of management committee relating to patent, regulatory, manufacturing, discovery, clinical, licensing & marketing; managing invention disclosures, patent applications, patent portfolios, foreign filing portfolios, & strategic licensing; personal drafting of 15-25 patent applications/year, managing worldwide patent portfolios for products on market & in development, including US, EU & Japanese patent prosecution, oppositions, appeals, litigation preparation, & arbitration.
  • Expert has developed, managed and implemented US, EU and Japanese patent pre-infringement, non-litigation or litigation strategies against competitors to support infringement, invalidity and potential cross-licensing of patent families, involving competing products in development, including interferences, reexams, and litigation preparation, such as invalidity, unenforceability and infringement analysis and strategy, technical analysis supporting invalidity, unenforceability and/or infringement case, and development of expert testing of asserted infringing product, witnesses, and testimony.
  • Expert has managed US, EU and Japanese arbitrations and patent litigation defense preparation for a hundreds of millions to multibillion dollar products for large global companies, including litigation analyses, patent invalidity and non-infringement analysis and strategies, technical analysis supporting non-infringement case, litigation management, and development of expert testing, witnesses, and testimony, often resulting in settlement and significant reduction in, or avoidance of, royalties to at least less than potential litigation costs
  • As an important example, Expert solely drafted, directly managed prosecution and initially managed the setting up of litigation of US patent 7.070,775, asserted by Centocor against Abbott that resulted in a record US$1.67 billion infringement verdict against Abbott in the Eastern District of Texas (07-cv-00139, E.D. Texas (Marshall)).
  • Specific examples of technologies that Expert has supported include research, diagnostic, and therapeutic technology, methods and apparatus relating to software, business methods, devices, and apparatus for diagnostic and therapeutic applications of small molecules, antibodies and antibody fusions, proteins, RNA and DNA; spectroscopy apparatus, mass spectroscopy, semiconductor laser diodes, LEDs, & flow cytometers; engine transmissions; chemical compounds, formulations and methods; DNA/RNA/protein conjugates, RNA and DNA amplification, sequencing and analysis, alternative expression systems including phage, bacteria, yeast, and mammalian cells; Phage display and transgenic animal DNA/RNA/protein and antibody library design, transformation, generation, screening, production and optimization. DNA, RNA and protein screening, analysis and engineering, Southern, Northern, Western blots, cloning, screening, selection, analysis, mass spectroscopy, kinetics, affinity off and on rates, crystallography and molecular modeling; DNA, RNA, and protein solubility and activity screening, selection and optimization, formulations, dosing, administration, devices.
Recent Client Requests:
  • Expert for consulting on licencing agreement.
  • IP Licensing biopharma expert for consulting on Webinar/Blog Participation.
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Expert Witness Experience Summary:
Europe and Asia. Expert has worked on international pharmaceutical and biotechnology patent litigation, including setting up and managing litigation and arbitration in the US, EU, and Japan . US Examples include: - Developing, managing, and implementing patent infringement action against competitor's multi-billion dollar biotechnology product based on issuance of 10 new US patents assertable against competitor, and for which 3 are currently being asserted, including validity, enforceability and infringement analysis and alternative litigation strategies, technical analysis supporting infringement case, and selection and development of expert testing of asserted infringing product, witnesses, and testimony. - Managing US arbitrations and patent litigation defense preparation for a multibillion dollar biotechnology product for a large global pharmaceutical company, including litigation analyses, patent invalidity and non-infringement analysis and strategies, technical analysis supporting non-infringement case, and development of expert testing, witnesses, and testimony, resulting in arbitration settlement before litigation initiated with significant reduction in royalties to an amount significantly less than expected litigation costs. - Developing, managing, and implementing patent pre-infringement, non-litigation procedures against competitor to support non-infringement, invalidity and potential cross-licensing of patent families, involving competing biotechnology products in development, including interferences, reexaminations, and litigation preparation, including validity, enforceability and infringement analysis and strategy, technical analysis supporting infringement case, and development of expert testing of asserted infringing product, witnesses, and testimony.
Recent Litigation Client Requests:
  • Endocrine expert in diabetes for consulting on the physical effects of diabetes on a person.
  • Expert in biotech patent malpractice litigation.
  • Trademark survey expert for consulting on medical data integration.
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

International Experience:
Years   Country / Region   Summary
1994 to 2009   European Union   In the European Patent Office, Expert has managed more than 15 patent oppositions & appeals, & managed prosecution of more than 150 EPO patent applications. Expert has also managed setting up and supporting EU arbitrations and patent litigation relating to multibillion dollar biotechnology products for a large global pharmaceutical company, including litigation analyses, patent invalidity and non-infringement analysis and strategies, technical analysis supporting non-infringement case, and development of expert testing, witnesses, and testimony, resulting in arbitration settlement before litigation initiated with significant reduction in royalties to an amount significantly less than expected litigation costs.

Expert has worked on more than 25 major due diligences, negotiations, and agreement drafting for multimillion to multibillion collaboration and licensing agreements with EU companies. Expert has also worked on more than 100 IP related agreements with EU companies.

1990 to 2008   Japan   In the Japan patent office, Expert has managed the prosecution of more than 100 patent applications & 10 appeals, including in person interviews.

Expert has also worked on international pharmaceutical & biotechnology dispute resolution & patent litigation, including patent arbitrations & litigation in Japan.

Expert has worked on more than 10 major due diligences, negotiations, and agreement drafting for multimillion to multibillion collaboration and licensing agreements with Japanese companies. Expert has also worked on more than 50 IP related agreements with Japanese companies.

1994 to 2008   Worldwide   In addition to managing more than 50 patent & regulatory product portfolios worldwide, Expert has drafted more than 500 international patent applications, prosecuted more than 1000 patent applications & managed worldwide patent prosecution for more than 500 patent families. Expert has conducted more than 100 major worldwide product & company transactional & IP due diligences, negotiations & agreements, as well as more than 1000 agreement negotiations & drafting, including worldwide academic, non-profit, government, feasibility, research, service, investigator initiated clinical studies, clinical studies & master agreements, manufacturing, product & technology licensing, know how & patent licenses, acquisitions, & product & technology out-licensing. Expert has worked on international pharmaceutical & biotechnology dispute resolution & patent litigation, including patent arbitrations & litigation in the US, EU, & Japan, and other countries.

Language Skills:
Foreign Language   Description
English   Expert in English
Spanish   Basic and limited ability to read, write and understanding, long experience reading and understanding Spanish patents and applications.
French   Basic and limited ability to read, write and understanding, long experience reading and understanding French patents and applications.

Market Research:
Expert has more than 20 years experience as in house and outside counsel involving all types of US and worldwide business development, acquisition, co-development, marketing, manufacturing and patent and know how licensing for discovery, therapeutic, diagnostic, and manufacturing biotechnology, pharmaceuticals, medical devices, and related technologies.

Expert has worked on more than 100 major, worldwide product and company acquisition and license agreements, including transactional, IP and regulatory due diligence, negotiations and agreement drafting. Expert has also worked on more than 1000 agreements, including due diligence, negotiations and drafting, including multi-product licensing, therapeutic area and technology licensing, co-promotion, co-development, multi-tiered and multi-party option agreements, medical and administration device feasibility, patent licensing, co-development and co-manufacturing, technology feasibility and option agreements, research, service, investigator initiated clinical study, clinical study and master agreements, manufacturing, product and technology licensing, know-how and patent licenses, and product and technology out-licensing.

Click the green button above to contact Expert for a free initial screening call regarding your marketing research, industry research, and company research needs.  For research needs involving multiple experts or secondary research, a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.  Remember, your initial screening call to speak with Expert is free.


Additional Skills and Services:
Training/Seminars

Expert IP Consulting: “Biotechnology and Pharmaceutical IP Due Diligence: Evolving Roles, Increasing Complexity and the Increasing Need for Experienced Counsel at Reasonable Cost.” Licensing Executive Society Annual Meeting, San Francisco, CA, October 18-21, 2009; Lovells, LLP: "Navigating the Genomics Business IP Landscape for Success: Considerations for Successful Genomics-Based Discovery, Development, Clinical Monitoring and Therapy", Business of Genomics, June 8, 2009, San Francisco, CA, Cambridge Healthcare Institute; Johnson & Johnson: "In-House Perspective on Managing IP Arbitrations" at Seminar "International Patent Arbitration and Dispute Resolution", Lovells LLP, NY, NY, May 8, 2008; Various legal & patent department committees, organizer, coordinator, & presenter. IP presentations & seminars to Centocor management, R&D, manufacturing, Product Teams, Pre-Clinical, Clinical, Medical Affairs, & Marketing, 2000-2008; Eli Lilly: Various legal & patent department committees, organizer, coordinator, & presenter for monthly patent topic meetings, 1998-2000; Sterne, Kessler et al.: Organized & presented training seminars for all attorneys & agents, 1994-1997, including current US, EU and Japanese patent law and licensing topics; Automation Committee (office computer systems evaluation & implementation), 1996-1998; Sughrue et al.: Organized & presented weekly training seminars for all attorneys & agents, 1990-1992; AIPLA/USPTO: "Patent Bar Perspectives on Considerations for Application Filing, Prosecution, Interferences & Litigation as a Result of the Implementation of the Biotechnology Sequence Listing Rules, 37 C.F.R. § 1.812-1.825"; San Francisco, California, January, 1991; Monthly Lectures for U.S.P.T.O. in Washington, D.C., February-July, 1991.

Other Skills and Services

Biopharma and Pharma Business Development, Licensing and cross-licensing IP and Know How, IP analysis, Freedom to operate, Portfolio management, IP prosecution and acquisition, Due diligence, Licensing, Acquisition, and General IP consulting services


 

Need the right expert?  We can help!

Privacy Policy   ©2013 ORC International - All Rights Reserved.